Arkansas Opioid Prescribing Guidelines: Limits, PMP, and Penalties

Arkansas opioid prescribing guidelines cap an initial acute-pain prescription at seven days, flag chronic-pain prescribing above 50 morphine milligram equivalents (MME) per day as excessive without documented justification, require the prescriber to check the state’s Prescription Drug Monitoring Program before writing any Schedule II or III opioid, and require naloxone to be co-prescribed in several high-risk situations. The rules live primarily in 17 CAR 85-109 for physicians and physician assistants, with parallel rules for dentists and advanced practice registered nurses. If you’re being prescribed an opioid in Arkansas for anything other than cancer, hospice, palliative, or end-of-life care, these are the limits shaping your prescription.

The Seven-Day Limit on Initial Acute-Pain Prescriptions

When you see a prescriber for a new episode of acute pain, whether it’s a broken bone, a surgical recovery, or a back injury, any initial opioid prescription longer than seven days counts as “excessive” unless your prescriber writes a detailed medical justification into your chart.1Code of Arkansas Rules. 17 CAR 85-109 – Prescribing and Dispensing Schedule II Narcotics The seven days apply to the first prescription for that specific pain episode, not to your lifetime opioid history.

The regulation also tells prescribers to start with the lowest effective dosage and to avoid long-acting or extended-release formulations as a first choice for acute pain. If your pain hasn’t resolved by the end of that first supply, you can get another prescription, but only after your prescriber re-evaluates you in person and documents why continued opioid therapy is still medically necessary.1Code of Arkansas Rules. 17 CAR 85-109 – Prescribing and Dispensing Schedule II Narcotics

The Mandatory PMP Check Before Your Prescription Is Written

Before writing any Schedule II or Schedule III opioid prescription, your prescriber is required by state law to check the Arkansas Prescription Drug Monitoring Program. This isn’t a suggestion, and it isn’t limited to first-time patients. It happens every time a Schedule II or III opioid is prescribed.2Justia. Arkansas Code 20-7-604 – Requirements for Prescription Drug Monitoring Program

The PMP is a statewide database of controlled substance prescriptions filled at Arkansas pharmacies. It shows your prescriber whether you have active opioid prescriptions from other providers, whether your fill patterns look unusual, and whether there are signs of misuse or diversion. For benzodiazepines, the check is required at least the first time the medication is prescribed to a new patient. Every licensing board with authority over controlled-substance prescribers must adopt rules enforcing the check.

What Changes Once Opioid Therapy Becomes Chronic

Chronic-pain prescribing gets significantly more demanding. Prescribing 50 MME per day or more for a non-exempt chronic-pain patient is defined as excessive unless the prescriber documents all of the following in the medical record:1Code of Arkansas Rules. 17 CAR 85-109 – Prescribing and Dispensing Schedule II Narcotics

  • Objective findings such as imaging, lab results, nerve conduction studies, or biopsies showing a pain-generating condition.
  • A written explanation of why 50 MME or more per day is necessary for you specifically.
  • Documentation of non-opioid therapies that were tried and failed or proved inadequate.
  • An assessment of your risk of abuse or diversion, plus confirmation that you were informed of the addiction risk.
  • Proof that the PMP was checked before the prescription was issued.
  • A detailed clinical rationale for continuing the prescription.

On top of this documentation, the prescriber has to see you in person at least once every 90 days to reassess whether the therapy is still necessary and still working.

The Written Treatment Agreement

Before chronic opioid therapy begins, you have to sign a written pain treatment agreement. It covers the addictive nature of the drug, what’s expected of both you and the prescriber, your consent to periodic urine drug screens and random pill counts, and the circumstances that would end the therapy.1Code of Arkansas Rules. 17 CAR 85-109 – Prescribing and Dispensing Schedule II Narcotics

Drug Screening

Urine drug screening does two things: it confirms you’re actually taking the prescribed medication rather than diverting it, and it checks for non-prescribed substances. Arkansas calls for baseline testing when chronic therapy starts and at least annual testing thereafter, consistent with CDC guidelines. Prescribers can order additional screens if they see reason to.

When Your Prescriber Must Co-Prescribe Naloxone

Arkansas requires prescribers to co-prescribe naloxone alongside your opioid in three situations:3Justia. Arkansas Code 20-13-1805 – Opioid Antagonist

  • Your prescribed dosage is 50 MME per day or higher.
  • You’ve been prescribed a benzodiazepine in the past, or you’re being prescribed one alongside the opioid.
  • You have a documented history of opioid use disorder or overdose.

A prescriber can decline to co-prescribe if they believe it isn’t in your best interest, but they have to record that decision in your chart. Failing to co-prescribe when required can result in a referral to the prescriber’s licensing board for discipline. Hospice and end-of-life patients are exempt from the co-prescribing rule.

If you’re receiving 50 MME per day or more and left the appointment without a naloxone prescription, ask about it. Naloxone can reverse an opioid overdose within minutes, and the CDC recommends that anyone in a higher-risk category keep it on hand.4Centers for Disease Control and Prevention. Lifesaving Naloxone

Who and What Falls Outside the Limits

The “excessive” prescribing thresholds and the associated documentation requirements don’t apply to patients in the following situations:1Code of Arkansas Rules. 17 CAR 85-109 – Prescribing and Dispensing Schedule II Narcotics

  • Active cancer treatment
  • Hospice care
  • Palliative care
  • End-of-life care
  • Residents of nursing homes or assisted living facilities
  • Inpatient hospital settings
  • Emergency situations

These exemptions affect the excessive-prescribing thresholds only. The PMP-check requirement still applies, and standard clinical judgment still governs the prescribing decision.

Two provider-specific limits are worth knowing because they can affect who writes your prescription. An APRN cannot prescribe Schedule II opioids for more than a five-day period; if you need more, you’ll be referred to a physician.5Justia. Arkansas Code 17-87-310 – Prescriptive Authority A dentist writing a Schedule II or III opiate is separately capped at seven days’ worth of the maximum recommended daily dose.6Legal Information Institute. 038.00.18 Ark. Code R. 005 – Article XX

Requesting a Partial Fill

If you’d rather not walk out of the pharmacy with the full quantity written on your prescription, federal law lets you request a partial fill of a Schedule II prescription. Either you or your prescriber can ask the pharmacy to dispense less than the full amount, and the remainder can be filled within 30 days of the date the prescription was written.7Office of the Law Revision Counsel. 21 USC 829 – Prescriptions The total across all partial fills can’t exceed the amount originally prescribed. The request doesn’t have to be made in person; a phone call, a signed note, or a caregiver with medical power of attorney can make it for you.

What Happens to Prescribers Who Break the Rules

Violating the Arkansas opioid prescribing rules is unprofessional conduct under the Arkansas Medical Practices Act, which defines unprofessional conduct to include violating any rule of the Arkansas State Medical Board, violating state or federal controlled substance laws, and grossly negligent malpractice.8Justia. Arkansas Code 17-95-409 – Denial, Suspension, or Revocation of License The Medical Board can revoke or suspend a license, impose probation, require counseling or treatment, or issue a reprimand. Other licensing boards have comparable tools for the prescribers they oversee.

Federal exposure is more severe. The DEA can suspend or revoke a prescriber’s controlled substance registration if their state license has been suspended or revoked, if they’ve been convicted of a felony related to controlled substances, if they’ve been excluded from federal healthcare programs, or if their conduct is deemed inconsistent with the public interest.9Office of the Law Revision Counsel. 21 USC 824 – Denial, Revocation, or Suspension of Registration Losing a DEA registration ends the ability to prescribe any controlled substance anywhere in the country.